A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Granisetron
Cortisone acetate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Cortisone acetate.
Granisetron
Corticotropin
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Corticotropin.
Granisetron
Trilostane
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Trilostane.
Granisetron
Fosphenytoin
The therapeutic efficacy of Vecuronium can be decreased when used in combination with Fosphenytoin.
Granisetron
Azosemide
Azosemide may decrease the neuromuscular blocking activities of Vecuronium.
Granisetron
Piretanide
Piretanide may decrease the neuromuscular blocking activities of Vecuronium.
Granisetron
Lithium cation
The risk or severity of adverse effects can be increased when Vecuronium is combined with Lithium cation.
Granisetron
Diethyl ether
The risk or severity of adverse effects can be increased when Vecuronium is combined with Diethyl ether.
Granisetron
Benzyl alcohol
The risk or severity of adverse effects can be increased when Vecuronium is combined with Benzyl alcohol.
Granisetron
Flibanserin
The risk or severity of adverse effects can be increased when Vecuronium is combined with Flibanserin.
Granisetron
Yohimbine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Yohimbine.
Granisetron
Ondansetron
The risk or severity of adverse effects can be increased when Ondansetron is combined with Vecuronium.
Granisetron
Lemborexant
The risk or severity of adverse effects can be increased when Vecuronium is combined with Lemborexant.
Granisetron
JNJ-26489112
The risk or severity of adverse effects can be increased when Vecuronium is combined with JNJ-26489112.
Granisetron
Solriamfetol
The risk or severity of adverse effects can be increased when Vecuronium is combined with Solriamfetol.
Granisetron
Bentazepam
The risk or severity of adverse effects can be increased when Vecuronium is combined with Bentazepam.
Granisetron
Pyrazolam
The risk or severity of adverse effects can be increased when Vecuronium is combined with Pyrazolam.
Granisetron
Cinazepam
The risk or severity of adverse effects can be increased when Vecuronium is combined with Cinazepam.
Granisetron
Oxazepam acetate
The risk or severity of adverse effects can be increased when Vecuronium is combined with Oxazepam acetate.
Granisetron
Perphenazine enanthate
The risk or severity of adverse effects can be increased when Vecuronium is combined with Perphenazine enanthate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3